Mn2+ administration intranasally, intravenously, or intratumorally induced robust systemic antitumor responses in all tested mouse models, with promoted NK cell function, DC and macrophage maturation/activation, CD8+ T cell differentiation/activation and memory T cell survival in tumors, and greatly inhibited tumor growth and metastasis. This evidence concerns the gene CD8A and neoplasm.